Patients With RA Benefit From Treatment With Biologic and Targeted DMARD Therapy

Press/Media: Research

Period	3 May 2022

Media coverage

Title	Patients With RA Benefit From Treatment With Biologic and Targeted DMARD Therapy
Degree of recognition	International
Media name/outlet	Rheumatology Advisor
Media type	Web
Country/Territory	United States
Date	3/05/22
URL	https://www.rheumatologyadvisor.com/news/biologic-sequential-targeted-dmards-benefit-rheumatoid-arthritis-ra/
Persons	Sizheng Zhao